166 related articles for article (PubMed ID: 22793852)
21. Human papillomavirus in metastatic lymph nodes from unknown primary head and neck squamous cell carcinoma.
Compton AM; Moore-Medlin T; Herman-Ferdinandez L; Clark C; Caldito GC; Wang XI; Thomas J; Abreo FW; Nathan CO
Otolaryngol Head Neck Surg; 2011 Jul; 145(1):51-7. PubMed ID: 21493313
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic utility of p16 immunocytochemistry in metastatic cervical lymph nodes in head and neck cancers.
Kapoor D; Handa U; Kundu R; Das A
Diagn Cytopathol; 2021 Apr; 49(4):469-474. PubMed ID: 33428334
[TBL] [Abstract][Full Text] [Related]
23. Population-based evidence of increased survival in human papillomavirus-related head and neck cancer.
Nygård M; Aagnes B; Bray F; Møller B; Mork J
Eur J Cancer; 2012 Jun; 48(9):1341-6. PubMed ID: 22516210
[TBL] [Abstract][Full Text] [Related]
24. Impact of HPV-related head and neck cancer in clinical trials: opportunity to translate scientific insight into personalized care.
Chung CH; Schwartz DL
Otolaryngol Clin North Am; 2012 Aug; 45(4):795-806. PubMed ID: 22793853
[TBL] [Abstract][Full Text] [Related]
25. [Metastatic oropharyngeal squamous cell carcinoma in cervical lymph nodes associated to HPV infection type 16 and 45; clinical, morphological and molecular study of two cases].
Soria-Céspedes D; Canchola Aguilar G; Lara-Torres CO; Sánchez-Marle JF; Hernández-Peña RE; Ortiz-Hidalgo C
Gac Med Mex; 2013; 149(6):673-9. PubMed ID: 24276191
[TBL] [Abstract][Full Text] [Related]
26. Human papilloma virus in head and neck cancer: the need for a standardised assay to assess the full clinical importance.
Braakhuis BJ; Brakenhoff RH; Meijer CJ; Snijders PJ; Leemans CR
Eur J Cancer; 2009 Nov; 45(17):2935-9. PubMed ID: 19766476
[TBL] [Abstract][Full Text] [Related]
27. Cytologic evaluation of cervical lymph node metastases from cancers of unknown primary origin.
Pusztaszeri MP; Faquin WC
Semin Diagn Pathol; 2015 Jan; 32(1):32-41. PubMed ID: 25618223
[TBL] [Abstract][Full Text] [Related]
28. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin.
Begum S; Gillison ML; Ansari-Lari MA; Shah K; Westra WH
Clin Cancer Res; 2003 Dec; 9(17):6469-75. PubMed ID: 14695150
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma.
Pinto AP; Schlecht NF; Pintos J; Kaiano J; Franco EL; Crum CP; Villa LL
Gynecol Oncol; 2004 Mar; 92(3):856-65. PubMed ID: 14984953
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus in metastatic squamous carcinoma from unknown primaries in the head and neck: a retrospective 7 year study.
Desai PC; Jaglal MV; Gopal P; Ghim SJ; Miller DM; Farghaly H; Jenson AB
Exp Mol Pathol; 2009 Oct; 87(2):94-8. PubMed ID: 19393644
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus type 16 oropharyngeal cancers in lymph nodes as a marker of metastases.
Mirghani H; Moreau F; Lefèvre M; Tam C; Périé S; Soussan P; St Guily JL
Arch Otolaryngol Head Neck Surg; 2011 Sep; 137(9):910-4. PubMed ID: 21930979
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Schultz JD; Mühlheim K; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
Oncol Rep; 2011 Nov; 26(5):1099-109. PubMed ID: 21805039
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of human papillomavirus in the survival of head and neck cancer patients: an overview of the evidence.
Schlecht NF
Oncol Rep; 2005 Nov; 14(5):1239-47. PubMed ID: 16211291
[TBL] [Abstract][Full Text] [Related]
34. Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma?
Thomas J; Primeaux T
Ann Diagn Pathol; 2012 Apr; 16(2):91-9. PubMed ID: 22197546
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus in head and neck cancers: biology, prognosis, hope of treatment, and vaccines.
Psyrri A; Boutati E; Karageorgopoulou S
Anticancer Drugs; 2011 Aug; 22(7):586-90. PubMed ID: 21403517
[TBL] [Abstract][Full Text] [Related]
36. High-risk human papillomavirus and cervical lymph node metastasis in patients with oropharyngeal cancer.
Joo YH; Jung CK; Sun DI; Park JO; Cho KJ; Kim MS
Head Neck; 2012 Jan; 34(1):10-4. PubMed ID: 21438064
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of human papillomavirus and other risk factors in Lithuanian patients with head and neck cancer.
Gudleviciene Z; Smailyte G; Mickonas A; Pikelis A
Oncology; 2009; 76(3):205-8. PubMed ID: 19209011
[TBL] [Abstract][Full Text] [Related]
38. HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior.
Kraft S; Faquin WC; Krane JF
Am J Surg Pathol; 2012 Mar; 36(3):321-30. PubMed ID: 22301491
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications.
Chung CH; Gillison ML
Clin Cancer Res; 2009 Nov; 15(22):6758-62. PubMed ID: 19861444
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations.
Szentirmay Z; Pólus K; Tamás L; Szentkuti G; Kurcsics J; Csernák E; Tóth E; Kásler M
Cancer Metastasis Rev; 2005 Jan; 24(1):19-34. PubMed ID: 15785870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
